Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (22)

2023

  1. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

    Journal of Bone and Mineral Research, Vol. 38, Núm. 4, pp. 471-479

  2. Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry

    Nefrologia, Vol. 43, Núm. 4, pp. 442-451

2022

  1. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

2021

  1. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial

    Journal of Bone and Mineral Research, Vol. 36, Núm. 10, pp. 1967-1978

  2. Multiple vertebral fractures after suspension of denosumab. A series of 56 cases

    International Journal of Clinical Practice, Vol. 75, Núm. 10

2020

  1. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease

    Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024

2019

  1. Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort

    Frontiers in Genetics, Vol. 10, Núm. FEB

  2. The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment

    Endocrine, Vol. 64, Núm. 3, pp. 441-455

2018

  1. Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients

    Nefrologia, Vol. 38, Núm. 5, pp. 520-527

  2. Severe, life-threatening phenotype of primary Sjögren's syndrome: Clinical characterisation and outcomes in 1580 patients (the GEAS-SS Registry)

    Clinical and Experimental Rheumatology, Vol. 36, pp. S121-S129

2017

  1. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520

  2. SNPs in bone-related miRNAs are associated with the osteoporotic phenotype

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. A comprehensive fracture prevention strategy in older adults: The European union geriatric medicine society (EUGMS) statement

    European Geriatric Medicine, Vol. 7, Núm. 6, pp. 519-525

  2. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease

    Kidney International, Vol. 90, Núm. 1, pp. 77-89

  3. Prevalence of thyroid dysfunction in women in early pregnancy: Does it increase with maternal age?

    Clinical Endocrinology, Vol. 84, Núm. 1, pp. 121-126

2015

  1. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185

  2. Plasma cardiotrophin-1 as a marker of hypertension and diabetes-induced target organ damage and cardiovascular risk

    Medicine (United States), Vol. 94, Núm. 30

2013

  1. Influence of body mass index on the association of weight changes with mortality in hemodialysis patients

    Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733

2011

  1. Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosis

    Toxicological Sciences, Vol. 122, Núm. 1, pp. 73-85

2010

  1. Differential effects of 17β-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency

    Menopause, Vol. 17, Núm. 4, pp. 766-771